Drug intelligence / Profile preview

Polyvalent Anti-Snake Venom Serum - Pan Africa

Development stage
Unknown
Lead developer
Premium Serums and Vaccines
Modality
Antibody-Based Therapeutics
Administration
Intravenous, Parenteral
01

Overview

Polyvalent Anti-Snake Venom Serum - Pan Africa (marketed as PANAF-Premium) is an equine-derived polyvalent antivenom developed and manufactured by Premium Serums and Vaccines. It consists of lyophilized, enzyme-refined equine F(ab')₂ immunoglobulin fragments designed to neutralize the venoms of 24 medically important snake species in sub-Saharan Africa, including species from the genera *Bitis*, *Echis*, *Naja*, and *Dendroaspis*. The product contains more than 60% venom-specific antibodies and is formulated as a lyophilized powder that does not require cold-chain storage, making it highly suitable for use in resource-limited settings. It is recommended by the World Health Organization (WHO) and is listed on the WHO Essential Medicines List for the treatment of snakebite envenomation.

Brand names
PANAF-Premium
Other names
Combipack Snake Venom Antiserum (Pan Africa)Combipack of Snake Venom Antiserum (Pan Africa)

Beyond the preview

Go deeper on Polyvalent Anti-Snake Venom Serum - Pan Africa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyvalent Anti-Snake Venom Serum - Pan Africa.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call